Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany
暂无分享,去创建一个
R. Schmid | J. Schneider | S. Weidlich | C. Spinner | B. Haller | C. Kirchhoff | J. Gempt | F. Gebhardt | C. Querbach | D. Hoffmann | R. Iakoubov | Johanna Koehler | B. Ritzer